During the past decade, CCOP - Southern Nevada Cancer Research Foundation conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 195 clinical trials were completed, i.e. on average, 928.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 63 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Southern Nevada Cancer Research Foundation" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 99 trials, followed by "National Cancer Institute (NCI)" with 84 trials sponsored, "Children's Oncology Group" with 61 trials sponsored, "Radiation Therapy Oncology Group" with 61 trials sponsored and "SWOG Cancer Research Network" with 61 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Southern Nevada Cancer Research Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 351 trials as a collaborator, "Cancer and Leukemia Group B" with 28 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "SWOG Cancer Research Network" with 23 trials as a collaborator and "Eastern Cooperative Oncology Group" with 22 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Southern Nevada Cancer Research Foundation" are "Breast Cancer" (41 trials), "Lung Cancer" (37 trials), "Prostate Cancer" (32 trials), "Leukemia" (30 trials) and "Lymphoma" (28 trials). Many other conditions were trialed in "CCOP - Southern Nevada Cancer Research Foundation" in a lesser frequency.

Most popular intervention types in "CCOP - Southern Nevada Cancer Research Foundation" are "Drug" (362 trials), "Other" (154 trials), "Biological" (135 trials), "Radiation" (116 trials) and "Procedure" (78 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (87 trials), "radiation therapy" (64 trials), "cyclophosphamide" (37 trials), "paclitaxel" (37 trials) and "cisplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Southern Nevada Cancer Research Foundation" are 357 trials for "All" genders, 67 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Southern Nevada Cancer Research Foundation". undefined are not yet recruiting, 3 are recruiting, 80 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 337 completed trials in CCOP - Southern Nevada Cancer Research Foundation, undefined suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Southern Nevada Cancer Research Foundation, 24 "Phase 1" clinical trials were conducted, 180 "Phase 2" clinical trials and 222 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".